| 'Hepatoma-specific'alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease PJ Johnson, N Leung, P Cheng, C Welby, WT Leung, WY Lau, S Yu, S Ho British journal of cancer 75 (2), 236-240, 1997 | 70 | 1997 |
| ‘Potentially curative therapies’ for hepatocellular carcinoma: how many patients can actually be cured? A Cucchetti, O Elshaarawy, G Han, CCN Chong, C Serra, JM O’Rourke, ... British Journal of Cancer 128 (9), 1665-1671, 2023 | 8 | 2023 |
| ‘Spontaneous’ regression of advanced leiomyosarcoma of the urinary bladder KIK Lei, E Gwi, L Ma, EY Liang, PJ Johnson Oncology 54 (1), 19-22, 1997 | 15 | 1997 |
| 10 years of SELDI: what have we learnt? W Wei, A Martin, PJ Johnson, DG Ward Current Proteomics 7 (1), 15-25, 2010 | 9 | 2010 |
| 2 The clinical features and natural history of malignant liver tumours PJ Johnson Baillière's Clinical Gastroenterology 1 (1), 17-34, 1987 | 12 | 1987 |
| 2327 Comparison between Child Pugh A5 vs A6 and ALBI grade 1 vs 2 in patients treated with sorafenib for HCC J Edeline, JF Blanc, P Johnson, P Ross, YT Ma, J King, R Hubner, ... European Journal of Cancer 3 (51), S441-S442, 2015 | | 2015 |
| 3500 ORAL Preliminary results from a phase II, randomized, double-blind study of sorafenib plus doxorubicin versus placebo plus doxorubicin in patients with advanced … GK Abou Alfa, P Johnson, J Knox, J Lacava, T Leung, A Mori, MA Leberre, ... EJC supplements 4 (5), 259, 2007 | 74 | 2007 |
| A comparison of the psychosocial impact of breast conserving therapy and total mastectomy in breast cancer patients and their partners W Yeo, WH Kwan, PML Teo, SY Nip, E Wong, W King, PJ Johnson European Journal of Cancer 33 (S8), S60-S60, 1997 | 1 | 1997 |
| A comparison of wound treatments in nasopharyngeal cancer patients receiving radiation therapy SS Mak, CY Zee, A Molassiotis, SJ Chan, SF Leung, KF Mo, PJ Johnson Cancer Nursing 28 (6), 436-545, 2005 | 39 | 2005 |
| A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization E Pang, N Wong, PBS Lai, KF To, JWY Lau, PJ Johnson Cancer genetics and cytogenetics 121 (1), 9-16, 2000 | 26 | 2000 |
| A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping N Wong, P Lai, E Pang, TWT Leung, JWY Lau, PJ Johnson Hepatology 32 (5), 1060-1068, 2000 | 118 | 2000 |
| A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma R Amoros, R King, H Toyoda, T Kumada, PJ Johnson, TG Bird Metron 77, 67-86, 2019 | 20 | 2019 |
| A controlled trial of colchicine in primary biliary cirrhosis: trial design and preliminary report TW Warnes, A Smith, FI Lee, NY Haboubi, PJ Johnson, L Hunt Journal of hepatology 5 (1), 1-7, 1987 | 155 | 1987 |
| A CONTROLLED TRIAL OF COLCHICINE IN PRIMARY BILIARY-CIRRHOSIS TW Warnes, A Smith, F Lee, NY Haboubi, PJ Johnson, L Hunt Hepatology 4 (5), 1022-1022, 1984 | 11 | 1984 |
| A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity TSK Mok, W Yeo, PJ Johnson, P Hui, WM Ho, KC Lam, M Xu, K Chak, ... Annals of Oncology 18 (4), 768-774, 2007 | 131 | 2007 |
| A framework for the molecular classification of circulating tumor markers PJ Johnson Annals of the New York Academy of Sciences 945 (1), 8-21, 2001 | 27 | 2001 |
| A joint United Kingdom (UK) and Hong Kong (HK) study to determine prognostic factors for hepatocellular carcinoma (HCC) undergoing curative and palliative treatment. SL Chan, PJ Johnson, F Mo, S Berhane, B Ma, M Teng, DMC Poon, ... Journal of Clinical Oncology 32 (3_suppl), 181-181, 2014 | 1 | 2014 |
| A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma TSK Mok, TWT Leung, SD Lee, Y Chao, ATC Chan, A Huang, MC Lui, ... Cancer chemotherapy and pharmacology 44, 307-311, 1999 | 70 | 1999 |
| A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma J Edeline, JF Blanc, P Johnson, B Campillo‐Gimenez, P Ross, YT Ma, ... Liver International 36 (12), 1821-1828, 2016 | 91 | 2016 |
| A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection BB Cai, KQ Shi, P Li, BC Chen, L Shi, PJ Johnson, P Lai, H Toyoda, ... Clinica Chimica Acta 485, 187-194, 2018 | 15 | 2018 |
